Xenon Pharmaceuticals Inc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | 100.0% | – | – | – | 100.0% | 100.0% | – | – | – | – | – | – | |
| 118.9% | 2.1% | 36,893.8% | 40,726.7% | 2,713.6% | 39,981.3% | 34,800.0% | – | – | 106.7% | – | – | 278.6% | 353.0% | 166.6% | 80.1% | 199.0% | 290.6% | 374.2% | 828.5% | 232.5% | 585.7% | 220.9% | 4,131.7% | 22,296.2% | 5,875.0% | – | – | – | 15.8% | – | – | – | 25.2% | – | – | – | – | – | – | – | |
| -18.9% | 97.9% | -36,793.8% | -40,626.7% | -2,613.6% | -39,881.3% | -34,800.0% | – | – | -6.7% | – | – | -178.6% | 100.0% | 100.0% | 100.0% | 100.0% | -190.6% | -274.2% | -728.5% | -132.5% | -485.7% | -120.9% | -4,031.7% | -22,196.2% | -5,775.0% | – | – | – | 84.2% | – | – | – | 50.0% | 100.0% | – | – | – | – | – | – | |
| 1,444.3% | 1,169.1% | 36,893.8% | 40,726.7% | 2,713.6% | 39,981.3% | 34,875.0% | – | – | 106.8% | – | – | 278.6% | 353.0% | 166.6% | 80.1% | 199.0% | 290.6% | 374.2% | 828.5% | 232.5% | 585.7% | 220.9% | 4,131.7% | 22,296.2% | 397,330.6% | – | – | – | 763.5% | – | – | – | 2,363.8% | 816.0% | – | – | – | – | – | – | |
| 430.8% | 383.5% | 13,125.0% | 11,993.3% | 660.6% | 10,437.5% | 13,987.5% | – | – | 33.8% | – | – | 77.1% | 95.4% | 46.9% | 24.7% | 48.9% | 60.3% | 94.3% | 285.8% | 59.5% | 179.0% | 77.3% | 1,624.1% | 6,688.6% | 96,977.0% | – | – | – | 234.6% | – | – | – | 715.6% | 253.8% | – | – | – | – | – | – | |
| 1,875.1% | 1,552.7% | 50,018.8% | 52,720.0% | 3,374.2% | 50,418.8% | 48,862.5% | – | – | 140.6% | – | – | 355.7% | 448.4% | 213.5% | 104.8% | 248.0% | 60.3% | 94.3% | 285.8% | 59.5% | 179.0% | 77.3% | 1,624.1% | 6,688.6% | 494,307.6% | – | – | – | 998.0% | – | – | – | 3,079.4% | 1,069.8% | – | – | – | – | – | – | |
| -1,775.1% | -1,452.7% | -49,918.8% | -52,620.0% | -3,274.2% | -50,318.8% | -48,862.5% | – | – | -140.6% | – | – | -255.7% | -348.4% | -113.5% | -4.8% | -148.0% | -250.9% | -368.5% | -1,014.3% | -192.0% | -664.7% | -198.1% | -5,655.8% | -28,884.8% | -494,307.6% | – | – | – | -998.0% | – | – | – | -3,079.4% | -969.8% | – | – | – | – | – | – | |
| 0.0% | 370.7% | 0.0% | 0.0% | 0.0% | 8,712.5% | 993.8% | – | – | 5.9% | – | – | 10.4% | 10.5% | 4.7% | 1.2% | 0.0% | 18.8% | 0.0% | 0.0% | 0.2% | 0.0% | 4.2% | 481.7% | 2,322.7% | 39,174.1% | – | – | – | 141.5% | – | – | – | – | – | – | – | – | – | – | – | |
| -1,867.8% | -1,596.8% | -46,981.3% | -49,200.0% | -2,932.6% | -50,406.3% | -23,468.8% | – | – | -142.6% | – | – | -253.3% | -342.8% | -105.8% | -1.6% | -138.2% | 239.6% | -363.3% | -1,006.6% | -192.6% | -671.1% | -228.9% | 5,820.5% | -28,588.6% | -413,598.0% | – | – | – | -835.5% | – | – | – | -2,763.6% | -861.6% | – | – | – | – | – | – | |
| 92.7% | 144.1% | -2,937.5% | -3,420.0% | -341.7% | 87.5% | 993.8% | – | – | 5.9% | – | – | 0.1% | -1.1% | 0.0% | -0.3% | -3.1% | 0.3% | -1.6% | -9.8% | -2.5% | 13.0% | -4.5% | 11,633.6% | -444.7% | 12,993.4% | – | – | – | -3.8% | – | – | – | -152.9% | 5.7% | – | – | – | – | – | – | |
| -1,867.8% | -1,596.8% | -46,981.3% | -49,200.0% | -2,932.6% | -50,406.3% | -23,468.8% | – | – | -142.6% | – | – | -253.5% | -341.7% | -105.7% | -1.3% | -135.1% | -239.3% | -361.7% | -996.8% | -190.1% | -684.1% | -224.4% | -5,813.1% | -28,143.9% | -426,591.4% | – | – | – | -831.7% | – | – | – | -2,610.7% | -867.3% | – | – | – | – | – | – | |
| -1,734.6% | -1,408.5% | -48,887.5% | -51,493.3% | -2,868.9% | -49,400.0% | -21,537.5% | – | – | -134.3% | – | – | -240.0% | -328.0% | -99.6% | 0.8% | -135.6% | -247.0% | -364.0% | -1,003.9% | -189.4% | -657.4% | -193.9% | -5,585.8% | -28,613.6% | -444,079.4% | – | – | – | -982.2% | – | – | – | -3,054.2% | -961.1% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.